InvestorsHub Logo
Followers 29
Posts 5703
Boards Moderated 3
Alias Born 02/03/2020

Re: J1989 post# 173433

Friday, 10/22/2021 9:00:44 PM

Friday, October 22, 2021 9:00:44 PM

Post# of 194981
I believe that most of us want that. I want to uplist, but not from a pps this low.

It's a tough call. The S-1 funding is obviously intended to startup the national tech service business. That might be difficult to accomplish without uplist, and with loans due.

The RXMD customer based business obviously functions expertly!

The pharmacy business stands on its own. They should be organized enough from integrating acquisitions that they can just start opening organic delivery locations, and build their own customer and physician base organically from their 5 star credentials, reputation, and local presence. Start with minimum staff and ramp up as needed. There is still a startup cost, robots, real-estate, staff, product, vehicles, insurance, etc. But I bet that organic cost is way below acquisitions. Some business could be partially serviced and/or supported from other locations.

IMO

Go RXMD!

I'm here to discover news and share opinions with other investors. All of my posts are my opinions and derivatives.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RXMD News